Martinez-Martin, F J <br/><br/>
Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.  [electronic resource] 

 -  Journal of human hypertension  Jun 2011 
 - 346-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5527 
<br/><br/><label>Standard No.: </label>10.1038/jhh.2010.104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adiponectin--blood<br/>Adult<br/>Aged<br/>Amlodipine--pharmacology<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure--drug effects<br/>C-Reactive Protein--metabolism<br/>Comorbidity<br/>Cytokines--blood<br/>Diabetes Mellitus, Type 2<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hydrochlorothiazide--pharmacology<br/>Hypertension--blood<br/>Imidazoles--pharmacology<br/>Incidence<br/>Insulin Resistance--physiology<br/>Intercellular Adhesion Molecule-1--blood<br/>Male<br/>Metabolic Syndrome--blood<br/>Middle Aged<br/>Prospective Studies<br/>Single-Blind Method<br/>Tetrazoles--pharmacology<br/>Treatment Outcome<br/>Vascular Cell Adhesion Molecule-1--blood